Humedix Co., Ltd.
Research Humedix Co., Ltd. (200670.KQ) on Bullrun: market cap KRW 268.98B, dividend yield 4.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker200670.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 268.98B
- Dividend yield4.8%
- Financial periodQ2 2026
- RevenueKRW 50.42B
- Net incomeKRW 2.45B
- Free cash flowKRW 71.80M
- Gross margin45.5%
Valuation Snapshot
latest market cap is KRW 268.98B; dividend yield is 4.8%.
Peer valuation comparison
Latest dividend yield is 4.79% versus a Healthcare sector median of 2.4% (99.6% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 268.98B | n/a | 4.8% | 1170 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1170 KRW, yield 4.8%.
About Humedix Co., Ltd.
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Humedix Co., Ltd.'s market cap?
Humedix Co., Ltd.'s market capitalization is KRW 268.98B.
Does Humedix Co., Ltd. pay a dividend?
Humedix Co., Ltd. has a dividend yield of 4.8%.
What does Humedix Co., Ltd. do?
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.